Clinical trial

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly…

NCT00352755 · Washington University School of Medicine, Other · Terminated

Key facts

NCT number NCT00352755
Title A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Official title A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
Lead sponsor Washington University School of Medicine, Other
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Peritoneal Neoplasms
Intervention type Drug, Procedure
Interventions Surgical debulking with peritonectomy, Intraperitoneal 5FU, FOLFOX
Enrollment 18
Start date May 1, 2006
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted Jul 17, 2006
Last update posted Dec 13, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies